Skip to content

Clinical trials

Lymphoma, B-Cell, Marginal Zone trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell, Marginal Zone Country / region: Netherlands Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20181
20201
20212
20222
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated4
Active, not recruiting2
Recruiting2
Completed1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC3
Genmab2
Incyte Corporation1
International Extranodal Lymphoma Study Group (IELSG)1
Lakefront Biotherapeutics NV1
MEI Pharma, Inc.1
Nurix Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell, Marginal Zone10
Lymphoma, Follicular8
Leukemia, Lymphocytic, Chronic, B-Cell7
Lymphoma, Large B-Cell, Diffuse5
Lymphoma, Mantle-Cell5
Lymphoma, Non-Hodgkin4
Burkitt Lymphoma3
Lymphoma3
Leukemia, Myeloid, Acute2
Lymphoma, Large-Cell, Immunoblastic2

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.